| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Sep―07 |
Laboratory adaptation of the SARS-CoV-2 Delta variant in Vero E6 cells enhances in vitro growth but attenuates human TMPRSS2-dependent fitness, pathogenicity, and transmission |
Jin Qiushi, Fang Yan, Fang Song, Wang Tiecheng, Xiang Haiyang, Shan Bingqi, Wang Xuefeng, Gao Yuwei, Xia Xianzhu |
| 2 |
[GO] |
2026―Aug―01 |
Genomic surveillance and evolutionary dynamics of SARS-CoV-2 variants in Yunnan, China, 2022-2025 |
Meifang Yang, Yang Liu, Zirui Zhang, Yingrong Du, Nihong Lu, Xianyao Yang, Xiaozhen Zhang, Jing Li, Xueshan Xia |
| 3 |
[GO] |
2026―Jun―07 |
Receptor-mimicking antibodies retain neutralization of recent SARS-CoV-2 variants |
Qi Tang, Liyuan Hu, Minxiang Xie, Ran Zhan, Qiao Wang, Rong Zhang |
| 4 |
[GO] |
2026―Apr―26 |
The PABS system under the pandemic agreement: Current status, controversies in negotiations, and future trends |
Qiqi Li, Zhen Xu, Jingcheng Wu, Xueqi Jiang, Changping Liu, Ana Paula Arez, Wagida Anwar, Io Hong Cheong, Wiku Adisasmito, Carmen C. Swanepoel, Shuiling Qu, Juncai Ma, Zisis Kozlakidis, Qiang Wei |
| 5 |
[GO] |
2026―Mar―17 |
Shifting seasonal patterns of influenza before, during and after the COVID-19 pandemic in Shanghai, China: A population-based surveillance study, 2015-2023 |
Yaxu Zheng, Yinzi Chen, Shenghua Mao, Genming Zhao, Qi Qiu, Shiying Yuan, Huilin Shi, Ruobing Han, Chenyan Jiang, Jian Chen, Huanyu Wu |
| 6 |
[GO] |
2025―Dec―20 |
Leveraging knowledge graphs and large language models for integrating molecular variants and clinical insights in COVID-19 research |
Jiaxin Yang, Fushuai Zhang, Ruifang Cao, Yingying Chen, Yiping Chen, Yuxin Chen, Yixue Li, Guoping Zhao, Ying Wang, Yunchao Ling, Guoqing Zhang |
| 7 |
[GO] |
2025―Nov―29 |
Impact of adjuvants on a recombinant SARS-CoV-2 spike vaccine: protective efficacy and recall antibody response following homologous challenge |
Dawei Wang, Zhendong Pan, Liangliang Jiang, Haoran Peng, Yanhua He, Yangang Liu, Xu Zheng, Cuiling Ding, Wanda Tang, Congcong Zhang, Xiaoyan Zhang, Jianqing Xu, Zhongtian Qi, Ping Zhao |
| 8 |
[GO] |
2025―Oct―18 |
Clinical characteristics of SARS-CoV-2 infection in patients with chronic hepatitis B during interferon antiviral therapy |
Shiyu Wang, Ziyu Zhang, Xinxin Li, Wen Deng, Yaqin Zhang, Weihua Cao, Xin Wei, Zixuan Gao, Linmei Yao, Shuojie Wang, Yao Xie, Minghui Li |
| 9 |
[GO] |
2025―Oct―05 |
Attribution of super-spreaders to the COVID-19 outbreak |
Rui Wang, Jianping Huang, Xinbo Lian, Yingjie Zhao, Shujuan Hu, Beidou Zhang |
| 10 |
[GO] |
2025―Sep―13 |
Predict SARS-CoV-2 genome interactions based on RNA language models |
Weiwei Shen, Yixue Li, Liucun Zhu, Tao Huang |
| 11 |
[GO] |
2025―Jul―16 |
Development of an identity test for COVID-19 mRNA vaccines using SARS-CoV-2 NAT standard |
Miran Jo, Eunjo Lee, Ho Jung Oh, Jin Tae Hong, Kyung Hee Sohn |
| 12 |
[GO] |
2025―Jan―18 |
Advances in the development of infectious clones of human coronaviruses and related applications |
Guangya Liu, Ruixiao Tan, Yiyi Wu, Mengwei Wang, Baoying Huang, Wenjie Tan |
| 13 |
[GO] |
2025―Jan―18 |
Integrative single-cell and metagenomic analysis dissects SARS-CoV-2 shedding modes in human respiratory tract |
Xiangxing Jin, Lili Ren, Xianwen Ren, Jianwei Wang |
| 14 |
[GO] |
2024―Oct―23 |
A comparative analysis of influenza and COVID-19: Environmental-ecological impacts, socioeconomic Implications, and future challenges |
Yongman Guo, Kuiying Gu, Paul A. Garber, Ruiling Zhang, Zijian Zhao, Lei Xu |
| 15 |
[GO] |
2024―Sep―03 |
Construction of pseudotyped human coronaviruses and detection of pre-existing antibodies in the human population |
Qi Jiang, Xi Wu, Fangyu Dong, Shan Qiao, Qiaoyun Shi, Changyong Jian, Chen Chen, Jiuyue Zhou, Youchun Wang, Weijin Huang |
| 16 |
[GO] |
2024―Sep―03 |
Drupacine as a potent SARS-CoV-2 replication inhibitor in vitro |
Chen Yang, Yanying Yu, Qi Peng, Jingwei Song, Bo Sun, Yi Shi, Qiang Ding |
| 17 |
[GO] |
2024―Jun―13 |
An online survey among convalescents 5 months post SARS-CoV-2 infection in China |
Yalan Wang, Maoshun Liu, Yuanyuan Guo, Min Li, Peipei Guo, Wenjun He, Tian Ma, Peipei Liu, Yaxin Guo, Beiwei Ye, Jun Liu, Guizhen Wu |
| 18 |
[GO] |
2024―Apr―30 |
Impact of ursodeoxycholic acid therapy in autoimmune liver disease patients with COVID-19 and its clinical prognosis |
Minghui Li, Weihua Cao, Tingting Jiang, Wen Deng, Shiyu Wang, Shuling Wu, Lu Zhang, Yao Lu, Min Chang, Ruyu Liu, Xiaoyan Ding, Ge Shen, Yuanjiao Gao, Hongxiao Hao, Xiaoxue Chen, Leiping Hu, Mengjiao Xu, Yuyong Jiang, Wei Yi, Yao Xie, Rui Song |
| 19 |
[GO] |
2024―Apr―19 |
Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines |
Ziyu Liu, Liyan Cai, Man Xing, Nan Qiao, Jiaojiao Liu, Xuejun Li, Chiyu Zhang, Naijun Tang, Zhelong Xu, Yingying Guo, Renfei Lu, Dongming Zhou |
| 20 |
[GO] |
2024―Mar―25 |
A novel method for identifying SARS-CoV-2 infection mutants via an epitope-specific CD8+ T cell test |
Congling Qiu, Bo Peng, Chanchan Xiao, Pengfei Chen, Lipeng Mao, Xiaolu Shi, Zhen Zhang, Ziquan Lv, Qiuying Lv, Xiaomin Zhang, Jiaxin Li, Yanhao Huang, Qinghua Hu, Guobing Chen, Xuan Zou, Xiaofeng Liang |
| 21 |
[GO] |
2024―Mar―05 |
Superior effectiveness and acceptability of saliva samples for the detection of SARS-CoV-2 in China |
Hui Yao, Ying Shen, Zhichao Liang, Xiaoyu Xue, Chenxi Zhao, Xiang Xu, Yuxin Cai, Yonghong Liu, Wei Zhang, Yang Pan, Xiaoli Wang |
| 22 |
[GO] |
2024―Mar―02 |
Genomic surveillance of emerging SARS-CoV-2 Omicron variations in Tianjin Municipality, China 2022 |
Xin Gao, Ming Zou, Yue Lei, Zhaolin Tan, Zhichao Zhuang, Baolu Zheng, Aiping Yu, Yanzhen Han, Xiaohui Lu, Xiaochang Liu, Ying Wang, Yuan Wang, Liru Guo, Guangwen Liu, Wen Li, Yang Liu, Likun Lv, Peiyong Ning, Xiaoyan Li |
| 23 |
[GO] |
2024―Feb―25 |
Prevalence of bacteria, fungi, and virus coinfections with SARS-CoV-2 Omicron variant among patients with severe COVID-19 in Guangzhou, China, winter 2022 |
Qinghong Fan, Mengling Jiang, Jun Zhang, Guofang Tang, Ming Gao, Yingfen Wen, Xizi Deng, Jun Dai, Honghao Lai, Peng Qian, Yaqing Lin, Ruiying He, Liya Li, Yueping Li, Zhengtu Li, Xuesong Liu, Yimin Li, Na Yu, Yun Lan, Fengyu Hu, Feng Li |
| 24 |
[GO] |
2023―Dec―31 |
Screening and identifying natural products with SARS-CoV-2 infection inhibitory activity from medicinal fungi |
Shuang Zhao, Amelia Siqi Huang, Weibo Zhang, Lili Ren, Hexiang Wang, Jianbin Wang, Xinyang Shao, Guanbo Wang |
| 25 |
[GO] |
2023―Dec―30 |
Efficacy of SARS-COV-2 detection from used surgical masks compared with standard detection method |
Uraporn Phumisantiphong, Anan Manomaipiboon, Yuttana Apichatbutr, Kittisak Pholtawornkulchai, Chunlanee Sangketchon, Busaba Supawattanabodee, Thananda Trakarnvanich |
| 26 |
[GO] |
2023―Dec―26 |
More common RNAemia in the early stage of severe SARS-CoV-2 BF.7.14 infections in pediatric patients |
Yu Sun, Runan Zhu, Yang Pan, Ri De, Shuang Liu, Liping Jia, Bing Lv, Xiaoyun Li, Dongmei Chen, Yao Yao, Dong Qu, Daitao Zhang, Linqing Zhao |
| 27 |
[GO] |
2023―Oct―21 |
Establishment and application of national reference panels for SARS-CoV-2 antigen detection kit |
Tingting Ma, Donglai Liu, Keliang Lyu, Tingting Gao, Dawei Shi, Lanqing Zhao, Shu Shen, Yabin Tian, Sihong Xu, Haiwei Zhou |
| 28 |
[GO] |
2023―Sep―14 |
Rare peptide anchors of HLA class I alleles contribute to the COVID-19 disease severity and T cell memory |
Xin Wang, Jie Zhang, Peipei Guo, Yuanyuan Guo, Xiaonan Yang, Maoshun Liu, Danni Zhang, Yaxin Guo, Jianbo Zhan, Kun Cai, Jikun Zhou, Shaobo Dong, Jun Liu |
| 29 |
[GO] |
2023―Sep―09 |
Role of innate immunity in SARS-CoV-2 infection |
Zihao Wang, Fang Cheng, Yuxiu Xu, Xin Li, Songdong Meng |
| 30 |
[GO] |
2023―Sep―02 |
Advances in treatment strategies for COVID-19: Insights from other coronavirus diseases and prospects |
Yingwen Li, Jiaming Lan, Gary Wong |
| 31 |
[GO] |
2023―Sep―02 |
Viral rebound and safety of nirmatrelvir/ritonavir for lung-transplant recipients infected with SARS-CoV-2 |
Hui Li, Li Zhao, Ke Huang, Xiaoxing Wang, Fei Zhou, Yiming Feng, Liang Ma, Bin Cao, Wenhui Chen |
| 32 |
[GO] |
2023―Jul―07 |
Forecast the potential SARS-CoV-2 variants in the future and predict their biological properties and social impacts from bioinformatics and public health perspectives |
Yixue Li, Yuming Guo, Tao Huang |
| 33 |
[GO] |
2023―Jul―04 |
On the collection and integration of SARS-CoV-2 genome data |
Lina Ma, Wei Zhao, Tianhao Huang, Enhui Jin, Gangao Wu, Wenming Zhao, Yiming Bao |
| 34 |
[GO] |
2023―May―09 |
Revealing the roles of TLR7, a nucleic acid sensor for COVID-19 in pan-cancer |
Zhijian Huang, Yaoxin Gao, Yuanyuan Han, Jingwen Yang, Can Yang, Shixiong Li, Decong Zhou, Qiuyan Huang, Jialiang Yang |
| 35 |
[GO] |
2023―Mar―04 |
Immunological considerations for laboratory staff and COVID-19 biosafety |
Ambroise Kouame Kintossou, Stephanie Villar, Zisis Kozlakidis |
| 36 |
[GO] |
2023―Mar―01 |
A Multiplex Method for Detection of SARS-CoV-2 Variants Based on MALDI-TOF Mass Spectrometry |
Ziyuan Zhao, Liying Sun, Liqin Wang, Xiaodong Li, Junping Peng |
| 37 |
[GO] |
2023―Jan―18 |
Towards precision medicine: Omics approach for COVID-19 |
Xiaoping Cen, Fengao Wang, Xinhe Huang, Dragomirka Jovic, Fred Dubee, Huanming Yang, Yixue Li |
| 38 |
[GO] |
2022―Dec―27 |
Factors Influencing COVID-19 Vaccination Intention among University Students: A Cross-Sectional Study in Malaysia |
Chee Yin Wong, Jen Sern Tham, Chai Nien Foo, Foong Leng Ng, Saleha Shahar, Mohd Nizam Zahary, Mohd Nazri Ismail, Cheng Siang Tan, Boon Peng Hoh, Subbiah Vijay Kumar, Yang Mooi Lim |
| 39 |
[GO] |
2022―Dec―27 |
Review of science and technology innovation policies in major Innovative-Oriented countries in response to the COVID-19 pandemic |
Tao Yun |
| 40 |
[GO] |
2022―Oct―28 |
Temporal dynamics of SARS-CoV-2 genome mutations that occurred in vivo on an aircraft |
Yaqing He, Shengyuan Dang, Wentai Ma, Long Chen, Renli Zhang, Shujiang Mei, Xinyi Wei, Qiuying Lv, Bo Peng, Ying Sun, Dongfeng Kong, Jiancheng Chen, Shimin Li, Xiujuan Tang, Qingju Lu, Can Zhu, Zhigao Chen, Jia Wan, Xuan Zou, Mingkun Li, Tiejiang Feng, Lili Ren, Jianwei Wang |
| 41 |
[GO] |
2022―Oct―28 |
An imported human case with the SARS-CoV-2 omicron subvariant BA.2.75 in Yunnan province, China |
Meiling Zhang, Zhixiao Chen, Jienan Zhou, Xiaonan Zhao, Yaoyao Chen, Yanhong Sun, Zhaosheng Liu, Wenpeng Gu, Chunrui Luo, Xiaoqing Fu, Xiang Zhao |
| 42 |
[GO] |
2022―Sep―23 |
Internet of Things (IoT) Imbedded Point-of-Care SARS-CoV-2 Testing in the Pandemic and Post-Pandemic Era |
Zhaoxi Wang, Simin Liu |
| 43 |
[GO] |
2022―Sep―09 |
Sequence difference of angiotensin-converting enzyme 2 between nonhuman primates affects its binding-affinity with SARS-CoV-2 S receptor binding domain |
Xiaojun Zhou, Jingjing Zhao, Yefeng Qiu, Rui Jia |
| 44 |
[GO] |
2022―Sep―07 |
Evaluation of factors contributing to variability of qualitative and quantitative proficiency testing for SARS-CoV-2 nucleic acid detection |
Yongzhuo Zhang, Xia Wang, Chunyan Niu, Di Wang, Qingfei Shen, Yunhua Gao, Haiwei Zhou, Yunjing Zhang, Yan Zhang, Lianhua Dong |
| 45 |
[GO] |
2022―Jul―13 |
Relatively rapid evolution rates of SARS-CoV-2 spike gene at the primary stage of massive vaccination |
Jing Yang, Min Han, Liang Wang, Likui Wang, Tianrui Xu, Linhuan Wu, Juncai Ma, Gary Wong, Wenjun Liu, George F. Gao, Yuhai Bi |
| 46 |
[GO] |
2022―Jul―09 |
Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks |
Balwir Matharoo-Ball, Mbayame Diop, Zisis Kozlakidis |
| 47 |
[GO] |
2022―Jun―28 |
Characterization and determinant factors of critical illness and in-hospital mortality of COVID-19 patients: A retrospective cohort of 1,792 patients in Kenya |
Isinta M Elijah, Endawoke Amsalu, Xuening Jian, Mingyang Cao, Eric K Mibei, Danvas O Kerosi, Francis G Mwatsahu, Wei Wang, Faith Onyangore, Youxin Wang |
| 48 |
[GO] |
2022―Jun―24 |
Advances in nanotechnology application in biosafety materials: a crucial response to COVID-19 pandemic |
Rasmi V. Morajkar, Akhil S. Kumar, Rohan K. Kunkalekar, Amit A. Vernekar |
| 49 |
[GO] |
2022―May―31 |
Possible processes and origin-tracing methods of “human-to-item” contamination and “item-to-human” infection with SARS-CoV-2 |
Ji Wang, Wenbo Xu, Xuejun Ma |
| 50 |
[GO] |
2022―May―26 |
Access and benefit-sharing of the pathogenic microorganisms such as SARS-CoV-2 |
Yalin Zhai, Geng Hong, Mengnan Jiang, Qiang Wei |
| 51 |
[GO] |
2022―May―12 |
Genomic characteristics of SARS-CoV-2 in Beijing, 2021 |
Zhaomin Feng, Shujuan Cui, Bing Lyu, Zhichao Liang, Fu Li, Lingyu Shen, Hui Xu, Peng Yang, Quanyi Wang, Daitao Zhang, Yang Pan |
| 52 |
[GO] |
2022―May―07 |
Screening for inhibitors against SARS-CoV-2 and its variants |
Weijing Yuan, Xiaojing Dong, Lan Chen, Xiaobo Lei, Zhuo Zhou, Li Guo, Jianwei Wang |
| 53 |
[GO] |
2022―May―05 |
Application of animal models to compare and contrast the virulence of current and future potential SARS-CoV-2 variants |
Zhe Ding, Tong Chen, Jiaming Lan, Gary Wong |
| 54 |
[GO] |
2022―Apr―28 |
An adjusted ELISpot-based immunoassay for evaluation of SARS-CoV-2-specific T-cell responses |
Hao Lin, Jie Zhang, Shaobo Dong, Yaning Liu, Peipei Liu, George F. Gao, William J. Liu, Guizhen Wu |
| 55 |
[GO] |
2022―Apr―25 |
Genetic differentiation and diversity of SARS-CoV-2 omicron variant in Its early outbreak |
Shenghui Weng, Jingzhe Shang, Yexiao Cheng, Hangyu Zhou, Chengyang Ji, Rong Yang, Aiping Wu |
| 56 |
[GO] |
2022―Apr―19 |
Importation of SARS-CoV-2 omicron variant in beijing, china |
Fu Li, Zhichao Liang, Shujuan Cui, Bing Lv, Zhaomin Feng, Hui Xu, Lei Jia, Peng Yang, Quanyi Wang, Yang Pan, Daitao Zhang |
| 57 |
[GO] |
2022―Apr―12 |
Case report: Long-term asymptomatic SARS-CoV-2 infection associated with deficiency on multiple immune cells |
Gang He, Xia Chuai, Dan Liang, Chunyu Chen, Changzheng Hu, Changwen Ke, Bixia Ke, Peilin Zhen, Huajun Zhang |
| 58 |
[GO] |
2022―Mar―04 |
Cell-cell communication analysis for single-cell RNA sequencing and its applications in carcinogenesis and COVID-19 |
Md Wahiduzzaman, Yuexing Liu, Tao Huang, Wu Wei, Yixue Li |
| 59 |
[GO] |
2022―Jan―19 |
Omicron variant of SARS-CoV-2 imposes a new challenge for the global public health |
Zepeng Xu, Kefang Liu, George F. Gao |
| 60 |
[GO] |
2022―Jan―04 |
Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles |
Sheng Wang, Lizhen Liu, Can Wang, Ziqiang Wang, Xuhua Duan, Gang Chen, Hu Zhou, Hong Shao |
| 61 |
[GO] |
2021―Dec―28 |
Laboratory biosafety measures of SARS-CoV-2 at containment level 2 with particular reference to its more infective variants |
Wafa Naeem, Habiba Zeb, Muhammad Ibrahim Rashid |
| 62 |
[GO] |
2021―Dec―25 |
Lack of evolutionary changes identified in SARS-CoV-2 for the re-emerging outbreak of COVID-19 in Beijing, china |
Yang Li, Yunjun Zhang, Mifang Liang, Yi Zhang, Xuejun Ma, Yong Zhang, Xiaohua Zhou |
| 63 |
[GO] |
2021―Dec―25 |
Forecasting COVID-19 situation in Bangladesh |
Mossamet Kamrun Nesa, Md. Rashed Babu, Mohammad Tareq Mamun Khan |
| 64 |
[GO] |
2021―Nov―14 |
Sirolimus Combined with Oseltamivir and Corticosteroid Treatment for a Puerpera with Severe Pneumonia Caused by 2009 Pandemic H1N1:A Case Report |
Lijun Suo, Xiaofeng Yu, Yongfeng Hu, Hongyun Cao, Xiaohui Zou, Peiquan Wang, Tao Xu, Xiangzhi Zhou, Yexin Wu, Lili Ren, Bo Liu, Bin Cao |
| 65 |
[GO] |
2021―Sep―13 |
Evaluating the effectiveness of control measures in multiple regions during the early phase of the COVID-19 pandemic in 2020 |
Zengmiao Wang, Jason Whittington, Hsiang-Yu Yuan, Hui Miao, Huaiyu Tian, Nils Chr. Stenseth |
| 66 |
[GO] |
2021―Sep―09 |
The impact of Sample Processing on the Rapid Antigen Detection test for SARS-CoV-2: Virus Inactivation, VTM Selection, and Sample Preservation |
Haiwei Zhou, Conghui Wang, Jian Rao, Lan Chen, Tingting Ma, Donglai Liu, Lili Ren, Sihong Xu |
| 67 |
[GO] |
2021―Aug―27 |
Expression pattern and function of SARS-CoV-2 Receptor ACE2 |
Rui-Ting Li, Cheng-Feng Qin |
| 68 |
[GO] |
2021―Aug―12 |
Environmental factors and their role in the transmission of SARS-CoV-2 |
Dawid Maciorowski, Divakar Sharma, Adinarayana Kunamneni |
| 69 |
[GO] |
2021―Jul―21 |
SARS-CoV-2 Spike Protein and RNA Dependent RNA Polymerase as Targets for Drug and Vaccine Development: A Review |
Yusuf Muhammed, Abduljalal Yusuf Nadabo, Mkpouto Pius, Bashiru Sani, Jafar Usman, Nasir Anka Garba, Ja'afaru Mohammed Sani, Basit Opeyemi Olayanju, Sunday Zeal Bala, Musa Garba, Misbahu Sambo |
| 70 |
[GO] |
2021―Jul―06 |
Surveillance of enteric pathogens in imported seafood and environmental surfaces in five seafood markets before the outbreak of COVID-19 |
Songzhe Fu, Wei Wang, Qingyao Wang, Fenglan He, Jingwei Hao, Bo Pang |
| 71 |
[GO] |
2021―Jun―04 |
Current knowledge of COVID-19: advances, challenges and future perspectives |
Yuhan Wu, Zhuobing Peng, Yongxue Yan, Jintao Hu, Yalong Wang, Xiaoyu Wang, Ruchao Peng, Daniel Watterson, Yi Shi |
| 72 |
[GO] |
2021―Jun―01 |
Virology features of a family cluster of SARS-CoV-2 infections in Shanghai, China |
Yanqiu Zhou, Zheng Teng, Hongyou Chen, Xiaoxian Cui, Fanghao Fang, Jiabin Mou, Hui Jiang, Xi Zhang |
| 73 |
[GO] |
2021―May―17 |
Comprehensive interactome analysis of the spike protein of swine acute diarrhea syndrome coronavirus |
Qingxing Wang, Yun Luo, Weijuan Shang, Zhengli Shi, Gengfu Xiao, Leike Zhang |
| 74 |
[GO] |
2021―Apr―30 |
Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations |
Omkar Indari, Budhadev Baral, Kartik Muduli, Ambika Prasad Mohanty, Natabar Swain, Nirmal Kumar Mohakud, Hem Chandra Jha |
| 75 |
[GO] |
2021―Mar―19 |
Finding the real COVID-19 case-fatality rates for SAARC countries |
Md. Rafil Tazir Shah, Tanvir Ahammed, Aniqua Anjum, Anisa Ahmed Chowdhury, Afroza Jannat Suchana |
| 76 |
[GO] |
2021―Feb―10 |
An update to monoclonal antibody as therapeutic option against COVID-19 |
Paroma Deb, Md. Maruf Ahmed Molla, K.M. Saif-Ur Rahman |
| 77 |
[GO] |
2021―Feb―06 |
Genetic diversity and genomic epidemiology of SARS-CoV-2 in Morocco |
Bouabid Badaoui, Khalid Sadki, Chouhra Talbi, Driss Salah, Lina Tazi |
| 78 |
[GO] |
2021―Jan―29 |
Technical specifications for the environmental monitoring of SARS-CoV-2 in farmers' (trade) markets in China |
|
| 79 |
[GO] |
2021―Jan―12 |
Review of pharmacologic and immunologic agents in the management of COVID-19 |
Marzuq A. Ungogo, Mustapha Mohammed, Bala N. Umar, Auwal A. Bala, Garba M. Khalid |
| 80 |
[GO] |
2020―Dec―30 |
Potential dual outbreak of COVID-19 and HFMD among children in Asia-pacific countries in the HFMD-endemic area |
Lina Jiang, Jing Wang, Bin Yu, Chuanyi Ning, Yi Tan |
| 81 |
[GO] |
2020―Dec―01 |
The COVID-19 pandemics and the relevance of biosafety facilities for metagenomics surveillance, structured disease prevention and control |
Thiago Moreno L. Souza, Carlos Medicis Morel |
| 82 |
[GO] |
2020―Nov―27 |
Convincing the confidence to conquer COVID-19: From epidemiological intervention to laboratory investigation |
William J. Liu |
| 83 |
[GO] |
2020―Nov―20 |
Cold-chain transportation in the frozen food industry may have caused a recurrence of COVID-19 cases in destination: Successful isolation of SARS-CoV-2 virus from the imported frozen cod package surface |
Peipei Liu, Mengjie Yang, Xiang Zhao, Yuanyuan Guo, Liang Wang, Jing Zhang, Wenwen Lei, Weifang Han, Fachun Jiang, William J. Liu, George F. Gao, Guizhen Wu |
| 84 |
[GO] |
2020―Nov―08 |
Coronavirus COVID- 19: A critical review of its history, pathogenesis, transmission, diagnosis and treatment |
Mohd Sharjeel Sofi, Aadil Hamid, Sami Ullah Bhat |
| 85 |
[GO] |
2020―Sep―25 |
Facing the 2020 Pandemic: What does Cyberbiosecurity want us to know to safeguard the future? |
Siguna Mueller |
| 86 |
[GO] |
2020―Sep―23 |
Spatiotemporal patterns and trends of community transmission of the pandemic COVID-19 in South Asia: Bangladesh as a case study |
Ariful Islam, Md Abu Sayeed, Md Kaisar Rahman, Jinnat Ferdous, Shahanaj Shano, Shusmita Dutta Choudhury, Mohammad Mahmudul Hassan |
| 87 |
[GO] |
2020―Sep―10 |
Estimation of the case fatality rate of COVID-19 epidemiological data in Nigeria using statistical regression analysis |
Ahmad Abubakar Suleiman, Aminu Suleiman, Usman Aliyu Abdullahi, Suleiman Abubakar Suleiman |
| 88 |
[GO] |
2020―Sep―02 |
Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020 |
Yong Zhang, Yang Pan, Xiang Zhao, Weifeng Shi, Zhixiao Chen, Sheng Zhang, Peipei Liu, Jinbo Xiao, Wenjie Tan, Dayan Wang, William Jun Liu, Wenbo Xu, Quanyi Wang, Guizhen Wu |
| 89 |
[GO] |
2020―Sep―02 |
Influenza activity during the outbreak of coronavirus disease 2019 in mainland China |
Mi Liu, Lizong Deng, Dayan Wang, Taijiao Jiang |
| 90 |
[GO] |
2020―Aug―21 |
Development and effectiveness of Pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro |
Ren Yang, Baoying Huang, A. Ruhan, Wenhui Li, Wenling Wang, Yao Deng, Wenjie Tan |
| 91 |
[GO] |
2020―Aug―05 |
Tackling COVID-19: Insights from the Qinghai Province Plague Prevention and Control (PPC) model |
Haisheng Wu, Qingwen Zhang, Hailian Wu, Fuzhang Tian, Baizhong Cui, Zhizhen Qi, Xiaoqing Xu, Xuefei Zhang, Hu Wang |
| 92 |
[GO] |
2020―Jul―23 |
Development of two TaqMan real-time reverse transcription-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2 |
Yiwei Liu, Yingying Wang, Xinming Wang, Yan Xiao, Lan Chen, Li Guo, Jianguo Li, Lili Ren, Jianwei Wang |
| 93 |
[GO] |
2020―Jul―15 |
Epidemiologic and clinical characteristics of 42 deaths caused by SARS-CoV-2 infection in Wuhan, China: A retrospective study |
Nan Zhang, Haochen Yao, Dong Zhang, Jiahui Pan, Ejun Peng, Juanjuan Huang, Yingli Zhang, Xiaoming Xu, Guobao Tian, Hong Xu, Guoqing Wang |
| 94 |
[GO] |
2020―Jul―09 |
Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment |
Yusuf Mummed |
| 95 |
[GO] |
2020―Jul―09 |
Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials? |
Asma Binte Aziz, Jennifer L. Dembinski, Yasmin Jahan |
| 96 |
[GO] |
2020―May―13 |
Charting the challenges behind the testing of COVID-19 in developing countries: Nepal as a case study |
Anil K. Giri, Divya R.S.B.B. Rana |
| 97 |
[GO] |
2020―May―12 |
Clinical characteristics of patients diagnosed with COVID-19 in Beijing |
Aihua Jin, Benyong Yan, Wei Hua, Dandan Feng, Bin Xu, Lianchun Liang, Caiping Guo |
| 98 |
[GO] |
2020―Apr―08 |
Laboratory biosafety guide for 2019-nCoV (Second Edition) |
National Health Commission of the People's Republic of China |
| 99 |
[GO] |
2020―Apr―02 |
Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy |
Marco D'Arienzo, Angela Coniglio |
| 100 |
[GO] |
2020―Feb―05 |
Technical guidance for laboratory testing of 2019-nCoV infection (third edition) |
|
| 101 |
[GO] |
2020―Feb―05 |
A strategy to prevent future pandemics similar to the 2019-nCoV outbreak |
Peter Daszak, Kevin J. Olival, Hongying Li |
| 102 |
[GO] |
2019―Dec―20 |
A novel luciferase immunosorbent assay performs better than a commercial enzyme-linked immunosorbent assay to detect MERS-CoV specific IgG in humans and animals |
Wenling Wang, Tianyu Wang, Yao Deng, Peihua Niu, A.A. Ruhan, Jincun Zhao, Malik Peiris, Shixing Tang, Wenjie Tan |
|
